Abstract
Postmortem brain studies have shown deficits in the cortical γ-aminobutyric acid (GABA) system in schizophrenic individuals. Expression studies have shown a decrease in the major GABA-synthesizing enzyme (glutamic acid decarboxylase (GAD67) mRNA levels in neurons in dorsolateral prefrontal cortex in schizophrenics relative to controls. In the present study, SNPs in and around the GAD1 gene, which encodes the protein GAD67, were tested on a rare, severely ill group of children and adolescents with childhood-onset schizophrenia (COS) (n=72), in a family-based association analysis. Compared to adult-onset samples, the COS sample has evidence for more salient familial, and perhaps genetic, risk factors for schizophrenia, as well as evidence for frontal cortical hypofunction, and greater decline in cortical gray matter volume on anatomic brain MRI scans during adolescence. We performed family-based TDT and haplotype association analyses of the clinical phenotype, as well as association analyses with endophenotypes using the QTDT program. Three adjacent SNPs in the 5′ upstream region of GAD1 showed a positive pairwise association with illness in these families (P=0.022–0.057). Significant transmission distortion of 4-SNP haplotypes was also observed (P=0.003–0.008). Quantitative trait TDT analyses showed an intriguing association between several SNPs and increased rate of frontal gray matter loss. These observations, when taken together with the positive results reported recently in two independent adult-onset schizophrenia pedigree samples, suggest that the gene encoding GAD67 may be a common risk factor for schizophrenia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Harrison PJ, Weinberger DR . Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2004.
Blum BP, Mann JJ . The GABAergic system in schizophrenia. Int J Neuropsychopharmacol 2002; 5: 159–179.
Kalkman HO, Loetscher E . GAD(67): the link between the GABA-deficit hypothesis and the dopaminergic- and glutamatergic theories of psychosis. J Neural Transm 2003; 110: 803–812.
Bu DF, Tobin AJ . The exon–intron organization of the genes (GAD1 and GAD2) encoding two human glutamate decarboxylases (GAD67 and GAD65) suggests that they derive from a common ancestral GAD. Genomics 1994; 21: 222–228.
Soghomonian JJ, Martin DL . Two isoforms of glutamate decarboxylase: why? Trends Pharmacol Sci 1998; 19: 500–505.
Asada H, Kawamura Y, Maruyama K, Kume H, Ding R, Ji FY et al. Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures. Biochem Biophys Res Commun 1996; 229: 891–895.
Asada H, Kawamura Y, Maruyama K, Kume H, Ding RG, Kanbara N et al. Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 1997; 94: 6496–6499.
Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WEJ et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 1995; 52: 258–266.
Lewis DA, Pierri JN, Volk DW, Melchitzky DS, Woo TU . Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry 1999; 46: 616–626.
Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA . Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 2000; 57: 237–245.
Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000; 57: 1061–1069.
Nicolson R, Rapoport JL . Childhood-onset schizophrenia: rare but worth studying. Biol Psychiatry 1999; 46: 1418–1428.
Childs B, Scriver CR . Age at onset and causes of disease. Perspect Biol Med 1986; 29: 437–460.
Bishop DT . BRCA1 and BRCA2 and breast cancer incidence: a review. Ann Oncol 1999; 10: 113–119.
St George-Hyslop PH . Genetic factors in the genesis of Alzheimer's disease. Ann NY Acad Sci 2000; 924: 1–7.
Asarnow RF, Nuechterlein KH, Fogelson D, Subotnik KL, Payne DA, Russell AT et al. Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study. Arch Gen Psychiatry 2001; 58: 581–588.
Hanson DR, Gottesman II . The genetics, if any, of infantile autism and childhood schizophrenia. J Autism Child Schizophr 1976; 6: 209–234.
Nicolson R, Brookner FB, Lenane M, Gochman P, Ingraham LJ, Egan MF et al. Parental schizophrenia spectrum disorders in childhood-onset and adult-onset schizophrenia. Am J Psychiatry 2003; 160: 490–495.
Sporn A, Greenstein D, Gogtay N, Sailer F, Hommer DW, Rawlings R et al. Childhood onset schizophrenia: smooth pursuit eye-tracking dysfunction in family members. Schizophr Res, in press.
Alaghband-Rad J, McKenna K, Gordon CT, Albus KE, Hamburger SD, Rumsey JM et al. Childhood-onset schizophrenia: the severity of premorbid course. J Am Acad Child Adolesc Psychiatry 1995; 34: 1273–1283.
Jacobsen LK, Hamburger SD, Van Horn JD, Vaituzis AC, McKenna K, Frazier JA et al. Cerebral glucose metabolism in childhood onset schizophrenia. Psychiatry Res 1997; 75: 131–144.
Sporn AL, Greenstein DK, Gogtay N, Jeffries NO, Lenane M, Gochman P et al. Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am J Psychiatry 2003; 160: 2181–2189.
Rapoport JL, Castellanos FX, Gogate N, Janson K, Kohler S, Nelson P . Imaging normal and abnormal brain development: new perspectives for child psychiatry. Aust NZ J Psychiatry 2001; 35: 272–281.
Straub RE, Egan MF, Goldberg TE, Callicott JH, Hariri A, Vakkalanka RK et al. GAD1, which encodes glutamate decarboxylase 1 (GAD 67), is associated with adult onset schizophrenia in two independent samples. Am J Med Genet 2003; 122B: 177.
Straub RE, Lipska BK, Egan MF, Goldberg TE, Callicott JH, Balkissoon R et al. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Am J Hum Genet, submitted.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC, 1994.
McKenna K, Gordon CT, Lenane M, Kaysen D, Fahey K, Rapoport JL . Looking for childhood-onset schizophrenia: the first 71 cases screened. J Am Acad Child Adolesc Psychiatry 1994; 33: 636–644.
Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P et al. Schedule for affective disorders and schizophrenia for school-age children—present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36: 980–988.
Ambrosini PJ . Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS). J Am Acad Child Adolesc Psychiatry 2000; 39: 49–58.
Hollis C . Child and adolescent (juvenile onset) schizophrenia. A case control study of premorbid developmental impairments. Br J Psychiatry 1995; 166: 489–495.
Cannon-Spoor HE, Potkin SG, Wyatt RJ . Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982; 8: 470–484.
Berument SK, Rutter M, Lord C, Pickles A, Bailey A . Autism screening questionnaire: diagnostic validity. Br J Psychiatry 1999; 175: 444–451.
Abecasis GR, Cherny SS, Cookson WO, Cardon LR . Merlin—rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30: 97–101.
Abecasis GR, Cookson WO . GOLD—graphical overview of linkage disequilibrium. Bioinformatics 2000; 16: 182–183.
Dudbridge F . Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115–121.
Abecasis GR, Cardon LR, Cookson WO . A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66: 279–292.
Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ et al. Linkage disequilibrium in the human genome. Nature 2001; 411: 199–204.
Ikeda K, Kawakami K . DNA binding through distinct domains of zinc-finger-homeodomain protein AREB6 has different effects on gene transcription. Eur J Biochem 1995; 233: 73–82.
Havik B, Ragnhildstveit E, Lorens JB, Saelemyr K, Fauske O, Knudsen LK et al. A novel paired domain DNA recognition motif can mediate Pax2 repression of gene transcription. Biochem Biophys Res Commun 1999; 266: 532–541.
Addington AM, Gornick M, Sporn AL, Gogtay N, Greenstein D, Lenane M et al. Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biol Psychiatry 2004; 55: 976–980.
Gornick M, Addington AM, Sporn AL, Gogtay N, Greenstein D, Lenane M et al. Dysbindin (DTNBP1, 6p22.3) is associated with childhood onset psychosis and endophenotypes measured by the Premorbid Adjustment Scale (PAS). J Autism Dev Disord, in press.
De Luca V, Muglia P, Masellis M, Jane Dalton E, Wong GW, Kennedy JL . Polymorphisms in glutamate decarboxylase genes: analysis in schizophrenia. Psychiatr Genet 2004; 14: 39–42.
O’Driscoll GA, Benkelfat C, Florencio PS, Wolff AL, Joober R, Lal S et al. Neural correlates of eye tracking deficits in first-degree relatives of schizophrenic patients: a positron emission tomography study. Arch Gen Psychiatry 1999; 56: 1127–1134.
Acknowledgements
We thank all of the families who participated in the COS study. We also express our gratitude to Michael Egan, Bhaskar Kolachana, Lew Bigelow, Thomas Hyde and coworkers in the Clinical Brain Disorders Branch Sibling Study, who contributed to the original discovery of association with GAD1 in the adult schizophrenia datasets and whose generous sharing of proprietary information and laboratory resources led to our initiation of this study in our sample. Finally, we thank two anonymous reviewers for their helpful comments and suggestions.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Molecular Psychiatry website (http://www.nature.com/mp)
Supplementary information
Rights and permissions
About this article
Cite this article
Addington, A., Gornick, M., Duckworth, J. et al. GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry 10, 581–588 (2005). https://doi.org/10.1038/sj.mp.4001599
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001599
Keywords
This article is cited by
-
A preliminary genetic association study of GAD1 and GABAB receptor genes in patients with treatment-resistant schizophrenia
Molecular Biology Reports (2022)
-
Association of lncRNA with regulatory molecular factors in brain and their role in the pathophysiology of schizophrenia
Metabolic Brain Disease (2021)
-
CRISPR/Cas9-engineered Gad1 elimination in rats leads to complex behavioral changes: implications for schizophrenia
Translational Psychiatry (2020)
-
GABAergic Abnormalities Associated with Sensorimotor Cortico-striatal Community Structural Deficits in ErbB4 Knockout Mice and First-Episode Treatment-Naïve Patients with Schizophrenia
Neuroscience Bulletin (2020)
-
Ulk4 regulates GABAergic signaling and anxiety-related behavior
Translational Psychiatry (2018)